Literature DB >> 8989617

Techniques for assessing neuroprotective drugs in vitro.

M P Goldberg1, U Strasser, L L Dugan.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 8989617     DOI： 10.1016/s0074-7742(08)60716-3

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN： 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  8 in total

1.  Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.

Authors:  Isaac T Schiefer; Lawren VandeVrede; Mauro Fa'; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-03-30       Impact factor: 7.446

2.  Human in vitro models of ischaemic stroke: a test bed for translation.

Authors:  Ana Antonic; Emily S Sena; Geoffrey A Donnan; David W Howells
Journal:  Transl Stroke Res       Date:  2012-07-21       Impact factor: 6.829

3.  Furoxans (Oxadiazole-4 N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory.

Authors:  Austin Horton; Kevin Nash; Ethel Tackie-Yarboi; Alexander Kostrevski; Adam Novak; Aparna Raghavan; Jatin Tulsulkar; Qasim Alhadidi; Nathan Wamer; Bryn Langenderfer; Kalee Royster; Maxwell Ducharme; Katelyn Hagood; Megan Post; Zahoor A Shah; Isaac T Schiefer
Journal:  J Med Chem       Date:  2018-05-07       Impact factor: 7.446

4.  Dendritic spines lost during glutamate receptor activation reemerge at original sites of synaptic contact.

Authors:  M J Hasbani; M L Schlief; D A Fisher; M P Goldberg
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

5.  On the regulation of ischaemia-induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone.

Authors:  R M Nelson; A R Green; D G Lambert; A H Hainsworth
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 6.  Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

Authors:  A M Mfuh; O V Larionov
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

7.  Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38alpha and p38beta activation and confers neuroprotection in the pheochromocytoma PC12 Model.

Authors:  Rinat Tabakman; Hao Jiang; Erik Schaefer; Robert A Levine; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.

Authors:  Philip D Loetscher; Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Astrid Fahlenkamp; Yu-Mi Ryang; Oliver Grottke; Mark Coburn
Journal:  Crit Care       Date:  2009-12-17       Impact factor: 9.097
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.